1-3 of 3
Alessandra Serrao, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) Is an Effective Regimen for Heavily Pretreated, Relapsed/Refractory Hodgkin Lymphoma Patients: A Multicenter, Retrospective Real-World Study

Antonio Russo, MD, Alessandro Pulsoni, MD, Simonetta Viviani, MD, Francesca Ricci, MD, Rita Mazza, MD, Massimo Magagnoli, MD, Lucia Morello, MD, Francesco Landi, MD, Anna Guidetti, MD, Michele Merli, MD, Marcello Rodari, MD, Alessandra Serrao, MD, Giorgia Annechini, MD, Andrea Nervini, MD, Laura Giordano, Luca Castagna, MD, Francesco Passamonti, MD, Arturo Chiti, MD, Paolo Corradini, MD, Armando Santoro, MD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1655.
https://doi.org/10.1182/blood-2018-99-115313
Published: 2018
Journal Articles

Long-Term Follow-up of Chronic Phase Chronic Myeloid Leukemia Patients Who Failed Interferon Alpha and Switched to Imatinib

Massimo Breccia, Giuseppina Loglisci, MD, Adriano Salaroli, MD, Alessandra Serrao, MD, Irene Zacheo, MD, Roberto Latagliata, MD, Giuliana Alimena
Journal: Blood
Blood (2012) 120 (21): 3742.
https://doi.org/10.1182/blood.V120.21.3742.3742
Published: 2012
Journal Articles

Delayed Cytogenetic Response and Reduced Rate of Major Molecular Response Associated to Increased Body Mass Index At Baseline in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Imatinib.

Massimo Breccia, Giuseppina Loglisci, MD, Adriano Salaroli, MD, Alessandra Serrao, MD, Paola Volpicelli, MD, Daniela Diverio, PhD, Roberto Latagliata, MD, Giuliana Alimena
Journal: Blood
Blood (2012) 120 (21): 2784.
https://doi.org/10.1182/blood.V120.21.2784.2784
Published: 2012